dr. oberstein on pegph20 in patients with pancreatic cancer
Published 6 years ago • 515 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
5:28
pegph20 in advanced pancreatic cancer
-
1:24
pegph20 with nab-paclitaxel/gemcitabine in pancreatic cancer
-
0:48
dr. hendifar on pegph20 survival impact in high hyaluronan pancreatic cancer
-
5:18
pegph20: a novel agent for pancreatic adenocarcinoma
-
0:47
dr. richards on parp inhibition in pancreatic cancer
-
2:01
dr. picozzi on prognostic value of pathologic response to chemo in pancreatic cancer
-
2:14
dr. tempero on the halo 301 trial for pancreatic cancer
-
1:46
dr. bekaii-saab discusses pegph20 in pancreatic adenocarcinoma
-
38:24
current and future directions in metastatic pancreatic cancer
-
1:48
dr. chung on sequencing chemotherapy regimens in metastatic pancreatic cancer
-
2:13
dr. fine on gtx in inoperable pancreatic cancer
-
1:07
dr. katz on neoadjuvant chemotherapy in pancreatic cancer
-
0:58
dr. weinberg discusses the use of folfirinox in older patients with metastatic pancreatic cancer
-
0:16
dr. weinberg discusses the use of folfirinox in older patients with metastatic pancreatic cancer
-
1:20
dr. o'reilly discusses biomarker research in pancreatic cancer
-
7:59
current practice with molecular testing in pancreatic cancer
-
0:57
dr. richards on using parp inhibitors in mutated metastatic pancreatic cancer
-
1:51
dr. o’reilly on investigational treatment approaches in pancreatic cancer
-
1:39
dr. simeone on selecting patients with pancreatic cancer for neoadjuvant therapy